Ojemda

Active Ingredient(s): Tovorafenib
FDA Approved: * April 23, 2024
Pharm Company: * DAY ONE BIOPHARMS
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ojemda 100 mg Oral Tablet, Film Coated
NDC: 82950-001
Labeler:
Day One Biopharmaceuticals, Inc.
OjemdaOjemda Kit
NDC: 82950-012
Labeler:
Day One Biopharmaceuticals, Inc.